Ray's profile was created using:
Sort By:

1-10 of 14 online sources for Ray Simkins

  • View Online Source
    www.sigroupplc.com/ray.shtml - [Cached Version]
    Published on: 3/19/2008    Last Visited: 3/19/2008  

    Ray SimkinsSurgical Innovations Group plc

    SI Group
    ...
    Ray Simkins
    ...
    Ray Simkins
    ...
    Ray is a mechanical engineer by training.He has worked for Getz since 1966 where he has represented their business interests in the US, Japan, Thailand, Malaysia and Singapore.

    Ray has been a non-executive Director
    ...
    Ray is a member of both the Surgical Innovations Audit and RemunerationsCommittees.

    Group Directors > Ray Simkins

  • View Online Source
    Bioheart Inc. Published Articles - [Cached Version]
    Published on: 11/20/2001    Last Visited: 12/3/2006  

    ' "Getz Medical's investment in Bioheart, Inc. represents an important stride forward in developing our product and technology base for the future," said Ray Simkins, President of Getz Medical's operations.

  • View Online Source
    Getz - [Cached Version]
    Published on: 6/22/2008    Last Visited: 6/22/2008  

    Mr Ray Simkins RaySimkins@getz.com

  • View Online Source
    Micrus Corporation Announces Distribution Agreements... - [Cached Version]
    Published on: 6/11/2002    Last Visited: 5/20/2008  

    According to Ray Simkins, President of Getz's medical division: "Including the Micrus product line is important to Getz's unique position in neurological medicine and will be the foundation for our entry into the Japanese and Asia Pacific endovascular neurological markets".

  • View Online Source
    Micrus Corporation Announces Distribution Agreements... - [Cached Version]
    Published on: 6/11/2002    Last Visited: 6/11/2002  

    According to Ray Simkins, President of Getz's medical division: "Including the Micrus product line is important to Getz's unique position in neurological medicine and will be the foundation for our entry into the Japanese and Asia Pacific endovascular neurological markets".

    About Micrus Corp.

    Micrus Corporation is a closely-held, private medical device company, which develops, manufactures and markets highly differentiated, proprietary devices and delivery systems for neuro endovascular applications.Micrus Corporation's advanced line of microcoils for the treatment of cerebral aneurysms has benefited thousands of patients in the United States, in Europe and in most countries of the world.Micrus Corporation serves the Americas and the Asia-Pacific region out of Mountain View, California and Europe, the Middle East and Africa out of Yverdon, Switzerland.

  • View Online Source
    Millimed - Board of Directors - [Cached Version]
    Published on: 8/23/2008    Last Visited: 8/23/2008  

    Ray Simkins Getz Brothers & Co., Inc.
    ...
    Ray Simkins - President, Getz Bros & Co.,Inc a diversified distributor in the Asia/ Pacific region.Mr Simkins joined Getz in 1966 and has held many positions throughout his career with them in the USA, Europe and Asia.His last assignment, prior to being made Global President, was to run the Healthcare businesses of Getz throughout the Asia region.Ray spent 15 years based in Japan building up the Heathcare business of Getz that is now heavily involved in pharmaceutical manufacturing and distribution as well as sales and service of medical devices and equipment.During his tenure with Getz he has interfaced with many major corporations - Merck, Roche, Bristol Myers Squibb, Medtronic, St.Jude, Guidant, Boston Scientific, Haemonetics and Datascope, . Ray also led the group's venture capital program and invested in many start-up companies in the USA, Europe and Japan as well as serving on their respective boards.

  • View Online Source
    Operating, Minimally Invasive, Medical, Healthcare - [Cached Version]
    Published on: 2/3/2001    Last Visited: 12/4/2001  

    -->Raymond Simkins - Non Executive Director.

    Ray Simkins is Chairman of Getz and Senior Vice President of Getz Bros.He has considerable knowledge of international markets with more than 25 years experience with Getz covering consumer, technical and medical products.For the past 17 years, he has focused on the Asian medical market and he has extensive knowledge of the cardiology and cardiac surgery sector.He has set up a larger number of distribution agreements and has been at the forefront of all of the Getz acquisitions during this period.

    Surgical Innovations Home

  • View Online Source
    Surgical Innovations Group plc - [Cached Version]
    Published on: 6/12/2000    Last Visited: 5/20/2004  

    Ray Simkins
    ...
    Ray (age 59) is a mechanical engineer by training and has qualifications from Buckingham Technical College and MIT.

    He has worked for Getz since 1966 where he has represented their business interests in the US, Japan, Thailand, Malaysia and Singapore.He is currently President of Getz Bros and Co., Inc. and is actively involved in their Far Eastern operations.

    Ray has been a non-executive Director since 1966 and was instrumental in securing investment from Getz prior to the reverse take-over of Haemocell plc in 1998.

    He has a wealth of experience in international distribution management and has a valuable input to many aspects of the Board's activities.

  • View Online Source
    The Marmon Group: Publications - Interchange / October... - [Cached Version]
    Published on: 12/20/2001    Last Visited: 3/25/2003  

    "When we started selling biomedical products in Japan over twenty years ago, no one in Japan was making these products," says Getz Japan president Ray Simkins."The Japanese had the money to pay for good health care but didn't have the products they needed.We simply plugged a hole."

    It was a big hole.Japan has a population of 125 million (almost half the size of the U.S.) and has a health care system that rivals the U.S. and Western Europe.While heart disease isn't common in Japan (last year about 200,000 people had heart attacks and 20,000 people had pacemakers implanted), the country has an aging population, necessitating a health care system that can accommodate the problems associated with aging.
    ...
    Again, Villafana chose Getz to market his product in Japan, and Nakajima and Ray Simkins -- then and now president of Getz Japan -- began rebuilding the Getz operation.
    ...
    Simkins, who had come to Japan from Getz's San Francisco office, began pursuing another biomedical equipment manufacturer called Pacesetter, Inc., to replace the lost CPI pacemaker business.
    ...
    "Since we don't believe in cost centers," says Simkins, "we thought we might make a business out of it."

    ...
    "For Pepsi, we designed OA Arena, a software package that enables their employees to switch between Japanese and English with the flip of a switch," says Simkins.For Levi's, Getz set up a network between the company's sales offices and warehouses so orders can be transmitted instantaneously and sales people can check stock on an item.

    Today, Getz Japan is a $250 million business that continues to grow by finding profitable new products not available in Japan.
    ...
    Still, Ray Simkins is unconvinced that past success is a guarantor of future prosperity.
    ...
    Because Getz represents medical product manufacturers (and thus does not make its own product) it does not control its destiny as much as Simkins would like.
    ...
    It's that possibility that drives Simkins and Nakajima and their employees to do the best job possible, and to continue to scout for new products to serve the Japanese market.

  • View Online Source
    Venture Capital Access Online | News - [Cached Version]
    Published on: 11/20/2001    Last Visited: 11/21/2001  

    "Getz Medical's investment in Bioheart, Inc. represents an important stride forward in developing our product and technology base for the future," said Ray Simkins, President of Getz Medical's operations."Bioheart's cell regeneration therapy is an exciting development in the treatment of patients who are suffering the effects of heart attack and heart failure, and fits strategically with our corporate objectives.We look forward to introducing and establishing Bioheart's technologies and products in Asia Pacific."

    Developing New Therapies to Treat Heart Patients

    Bioheart's principal initial product under development is called MyoCell(TM), which is designed to regenerate damaged muscle tissue through the transplantation of skeletal muscle cells.

Page:  1 2 Next

Wrong Person?

Related searches
More...
For Recruiters For Sales Pros

Copyright © 2008 Zoom Information Inc. All rights reserved.

BPS_S5.0.5_newui_RC002_P001.1 OM17